Karaciğer Malignitelerinde Girişimsel Radyolojik İşlemler

Shi, W., et al. Comparative efficacy of radiofrequency ablation versus resection for small hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials. Eur J Gastroenterol Hepatol. 2021;33(2):e223-e230.

Facciorusso, A., et al. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis of efficacy and safety. J Cancer Res Clin Oncol. 2020;146(2):427-434.

Di Leva, G., et al. Microwave ablation versus radiofrequency ablation for small hepatocellular carcinoma: a long-term retrospective study. J Clin Med. 2023;12(15):4974.

Scheffer, H. J., et al. Irreversible electroporation for the treatment of liver tumors: current consensus and future directions. Eur Radiol. 2021;31(1):166-177.

Reig, M., et al. BCLC subclassification and treatment strategy. J Hepatol. 2022;76(1):135-151.

Di Leva, G., et al. Microwave ablation versus radiofrequency ablation for small hepatocellular carcinoma: a long-term retrospective study. J Clin Med. 2023;12(15):4974.

Lee, M. K., et al. Primary treatments for solitary hepatocellular carcinoma ≤3 cm: A systematic review and network meta-analysis. Ann Hepato-Biliary-Pancreatic Surg. 2024;28(3):264-274.

Facciorusso, A., et al. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis of efficacy and safety. J Cancer Res Clin Oncol. 2020;146(2):427-434.

Di Leva, G., et al. Microwave ablation versus radiofrequency ablation for small hepatocellular carcinoma: a long-term retrospective study. J Clin Med. 2023;12(15):4974.

Lee, M. K., et al. Primary treatments for solitary hepatocellular carcinoma ≤3 cm: A systematic review and network meta-analysis. Ann Hepato-Biliary-Pancreatic Surg. 2024;28(3):264-274.

Pini, M., et al. The role of local ablation for colorectal cancer liver metastases. Cancers (Basel). 2023;15(15):3876.

Scheffer, H. J., et al. Irreversible electroporation for the treatment of liver tumors: current consensus and future directions. Eur Radiol. 2021;31(1):166-177.

Narayanan, G., et al. Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future Avenues. Semin Intervent Radiol. 2024;41(1):103-111.

Lencioni, R., et al. Sorafenib in combination with transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a Phase III study. J Clin Oncol. 2012;30(34):4346-4353.

Vogl, T. J., et al. Doxorubicin-loaded beads versus conventional transarterial chemoembolization for hepatocellular carcinoma. Clin Cancer Res. 2011;17(10):3316-3323.

Salem, R., et al. Yttrium-90 microspheres for the treatment of unresectable hepatocellular carcinoma. Gastroenterology. 2014;147(4):797-809.

Peng, Z. W., et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: an observational study. Hepatology. 2013;57(5):1832-1842.

Reig, M., et al. BCLC subclassification and treatment strategy. J Hepatol. 2022;76(1):135-151.

Lewandowski, R. J., et al. Yttrium-90 microsphere safety and efficacy in chemoembolization refractory hepatocellular carcinoma. J Hepatol. 2013;58(5):940-948.

Kudo, M. Ablation therapy and its current status in the treatment of hepatocellular carcinoma: updated review. Oncology. 2020;98(5):341-351.